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Abstract
Post-traumatic stress disorder (PTSD) is a mental health condition that affects
people after instances of severe emotional trauma. Research suggests that oxytocin
treatment decreases PTSD symptoms. This study served to evaluate the efficacy of
intranasal oxytocin pre-treatment on symptoms related to PTSD. The hypotheses
are that oxytocin will decrease fear and anxiety, and increase reward-seeking
behaviors. Sprague Dawley rats were assigned to three groups (Control, Stress,
Oxytocin, and Oxytocin+Stress; n=6 per group) to conduct this experiment. Prior to
foot shock treatment, rats were trained to expect a food reward (Kellogg’s Froot
Loops) in an open field enclosure. Subsequently, the Oxytocin and the
Oxytocin+Stress groups were pre-treated with intranasal oxytocin and then the
Stress and Oxytocin+Stress groups were exposed to an inescapable foot shock (a
model PTSD inducing stressor). After oxytocin and shock treatments, rats
underwent various behavioral tests: re-exposure to the shock chamber to assess
fear, elevated O-maze to assess anxiety, and food reward trials in the open field
enclosure to assess reward-seeking behavior. The oxytocin treatment decreased
fear related symptoms upon re-exposure to the fear conditioning chamber; both
colonic motility and freezing time were lower in the Oxytocin+Stress group
compared to the Stress group. The foot shock model failed to produce significant
behavioral changes related to anxiety and reward-seeking behavior between the
Control and Stress groups.
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Background and Significance
PTSD
Post-traumatic stress disorder (PTSD) is a mental health condition that affects
people after instances of severe emotional or physical trauma. Diagnostic criteria
are complex and symptoms vary between individuals, but include emotional
distress, physical reactivity, avoidance of trauma related reminders, decreased
interest in activities, and difficulty experiencing positive affect (American
Psychiatric Association, 2013). It is estimated that between 8.3% and 9.4% percent
of the United States population develops diagnosable PTSD in their lifetime
(Kilpatrick et al., 2013).
Rodent Model of PTSD
While previous researchers have used corticosterone administration to induce
symptoms of PTSD in rodents (Levy et al., 2001), more recently a fear-conditioning
paradigm using chronic electric foot shock (described in the Methods section) has
been developed to induce PTSD-like symptoms in a rat model (Sahraei et al., 2012;
Yu et al., 2012; Gao et al., 2014) . This paradigm produces behavioral changes in rats
such as fear and anxiety, which are known to be associated with PTSD.
Fear in rats is commonly assessed by increased freezing behavior (Fanselow,
1994; Sahraei et al., 2012; Yu et al., 2012; Gao et al., 2014). Freezing is defined as
motionless periods upon re-exposure to the previously traumatizing source of
stimuli, the foot shock chamber (Yu et al., 2012; Gao et al., 2014), and is a hallmark
of stress-induced behavioral changes in rodents. Another assessment of fear in
rodents is increased defecation when re-exposed to fear related stimuli (Lester et al.,

1968; Gao et al., 2011). Increased defecation, often referred to as “colonic motility”,
is a measure highly sensitive to psychological stress (Stam et al., 1995). Colonic
motility is thought to be regulated by the release of corticotropin-releasing hormone
caused by stressful events (Verleye & Gillardin, 2004).
Anxiety is commonly manifested and measured in rodents as decreased
locomotion (Fernandes et al., 1999; Prut & Belzung, 2002) and increased time in
enclosed spaces (Pellow et al., 1985; Shepherd et al., 1994; Ennaceur et al., 2006).
Many different methods have been used to assess anxiety in rodents and include the
open-field test, elevated plus-maze, and elevated O-maze (reviewed in Sestakova et
al., 2013). The open-field test is the simplest and longest used anxiety test for rats,
dating back to 1930’s (Hall and Ballachey, 1932). While specific requirements of the
open-field are not standardized, in general it consists of an open area in which
ambulation can be observed (Walsh and Cummings, 1976). The test measures
locomotion and propensity to explore; lower amounts of locomotion and
exploration correlate to higher levels of anxiety (Perals et al., 2017; Prut and
Belzung 2003). The elevated plus-maze is a four-armed maze that is raised off the
ground by legs. Each arm is connected at a center platform. Two arms of the plusmaze have high walls and the other two arms do not have walls. The time spent in
the walled areas is associated with anxious behavior (Pellow et al., 1984; Rodgers
and Dalvi, 1997) as the rat is thought to be avoiding the novelty of the open area
(Dawson & Tricklebank, 1995). The elevated O-maze (or elevated zero-maze) was
developed as an improvement to the elevated plus-maze. The concepts of the plusmaze, such as height off the ground and the open versus closed areas, remain the
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same but the O-maze forms a continuous circle (or zero) with alternating quadrants
of open (no walls) and closed (walled off) areas. This configuration allows for easier
exploration between maze sections since there are no corners and the rats do not
have to turn around while continuing to move about the maze (Shepherd et al.,
1994). It has been suggested that the elevated O-maze produces more consistent
results over time (Tucker & McCabe, 2017); however, the results of the elevated Omaze are diminished by daily re-exposure (Cook et al., 2001).
Anhedonia (the decrease in the capacity to feel pleasure) has relatively
recently been incorporated into the diagnostic criteria of PTSD (Stein et al., 2014). It
is thought that PTSD may be associated with reward-seeking impairments. While
the response is varied, there seems to be an overall decrease in reward anticipation,
approach (or wanting), and hedonic responses to reward (Nawijn et al., 2015). This
symptom of PTSD, observed in humans, has not yet been investigated in the rodent
model. Reward seeking in rodents is most commonly assessed by the use of an
operant box (Dingess et al., 2017; Piantadosi et al., 2017). Since operant boxes are
currently not available in our lab, one of the goals of this study was to investigate
the impact of stress on the reward-seeking behavior in an open field circular
enclosure (described in the Methods section). Furthermore, a recent study
conducted by Nawijn et al. (2016) suggests that oxytocin treatment in humans with
PTSD appears to impact the brain regions involved in reward processing. Therefore,
another goal of this study was to investigate the impact of oxytocin on PTSD-related
behaviors (i.e., fear, anxiety, and reward-seeking).
Oxytocin
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Oxytocin is a neurohormone produced by neurons of the paraventricular and
supraoptic nuclei in the hypothalamus. It is associated with many functions of the
body including human emotion and motivation (Love, 2014). Administered after
traumatization, oxytocin has been shown to reduce symptoms associated with PTSD
(i.e., fear and anxiety) in both rodent (Missig et al., 2010; Ayers et al., 2011; Zoicas et
al., 2014; Janezic et al., 2016; Sack et al., 2017) and human clinical trials
(Bakermans-Kranenburg & Van IJzendoorn, 2009; Acheson et al., 2013; Frijiling et
al., 2014).
Oxytocin is a neuropeptide that directly interacts with oxytocin receptors in
specific parts of the central nervous system, as such it is considered a
neuromodulator in brain regions associated with fear, aggression and social
behaviors (Febo & Ferris, 2014; Heinrichs & Domes, 2008). Oxytocin receptors are
expressed in the amygdala, which is an area of the brain intimately involved in
processing of emotion and cognition (reviewed in Phelps, 2006). Furthermore,
oxytocin receptors are also found in reward processing areas of the brain (Febo and
Ferris, 2014) including the ventral tegmental area and the nucleus accumbens (Wise
and Bozarth, 1987; Nicola, 2016). Hypothalamic oxytocin neurons have direct
axonal connections to the amygdala, ventral tegmental area, and nucleus accumbens
and are thought to directly modulate the activity of these brain regions (Bethlehem
et al., 2012).
In addition to its direct effects on brain regions associated with the
processing of emotions and motivation, oxytocin also interacts with the
hypothalamic-pituitary-adrenal (HPA) axis. This endocrine feedback system is
4

implicated in stress reactions as well as regulating many body processes (Bhatnagar
et al., 2006; Stranahan et al., 2008; Hall et al., 2012; Daskalakis et al., 2013). The HPA
axis can be modified permanently by early childhood trauma, rendering it hyper
reactive (van Bodegom et al., 2017). Oxytocin has been shown to inhibit stress
responses associated with the HPA axis such as corticosterone release (Windle et al.,
1997; Heinrichs et al., 2003; De Kloet et al., 2006). As a natural mechanism, oxytocin
offers protection to stress associated with the HPA axis in postpartum,
breastfeeding mothers (Cox et al., 2014). Oxytocin levels rise peripherally following
stressful incidents and higher oxytocin levels correspond to faster recovery from
stress related symptoms (Engert et al., 2016). Therefore, oxytocin treatment could
potentially provide neuroprotection during stressful events.
Prophylaxis
Various pharmaceutical and psychosocial interventions have been studied as
potential preventative treatments for PTSD (reviewed in Baker et al., 2009;
Daskalakis et al., 2013). Most preventative measures that have been explored fall
into the category of “early intervention” in which treatment is given after the
traumatic event, but prior to development of PTSD related symptoms (reviewed in
Birur et al., 2017). Multiple drugs have been studied as potential preventative
treatments for PTSD (Vaiva et al., 2003; Baker et al., 2009; Daskalakis et al., 2013,
Morena et al., 2017). However, the efficacy of oxytocin as a prophylactic, or
preventative, treatment has been minimally explored in humans (Frijling et al.,
2014; van Zuiden et al., 2017) and there is a dearth of research with rodents
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(Renicker et al., 2015). Oxytocin may offer the same neuroprotective benefits of
other treatments (Vaiva et al., 2003; Baker et al., 2009; Daskalakis et al., 2013,
Morena et al., 2017) without the risks associated with long-term treatment,
including antidiuresis and hyponatremia (Baker et al., 2009).

Intranasal Administration
Intranasal administration of oxytocin is an effective therapeutic delivery
method in humans (Fischer-Shofty et al., 2010; Guastella et al., 2010; Acheson et al.,
2013; Nawijn et al., 2016). While the mechanisms are not clearly understood,
intranasal oxytocin administration produces “clear and specific changes in neural
activation” (Veening & Olivier 2013) and has been shown to increase levels of
oxytocin in cerebral spinal fluid (Stevens et al. 2013, Streipens et al., 2013).
Intranasal oxytocin administration has also been shown to impact specific brain
regions considered ‘social’ regions (Bethlehem et al., 2012). Oxytocin is a very small
peptide of nine amino acids (a nonapeptide) and is believed to at least partially pass
through the blood brain barrier (Ermisch et al., 1985). Oxytocin administrated
intranasally is thought bypass the blood brain barrier (Talegaonkar & Mishra 2004)
and has been shown to produce higher levels of oxytocin in the brain than
peripheral administration (Neumann et al., 2013). Additionally, peripheral oxytocin
may have different effects on stress than oxytocin delivered directly into the central
nervous system via intranasal administration. One study found that increased
6

plasma oxytocin levels correlate to increased cortisol levels (Taylor et al., 2006),
although causation was not implied. Research suggesting that intranasal
administration of oxytocin directly and effectively impacts brain function warrants
investigation into its potential therapeutic effects on conditions such as PTSD.
The purpose of this study was to test the hypothesis that prophylactic
oxytocin treatment with decrease PTSD related symptoms in a rat model,
specifically decreasing fear and anxiety related behaviors and increasing rewardseeking behaviors.
Methods
Twenty-four male Sprague Dawley rats were randomly assigned to four
groups (n=6, per group): 1. Control group (no shock and no oxytocin treatment), 2.
Stress group (exposed to shock and no oxytocin treatment), 3. Oxytocin group (no
shock and treated with oxytocin), and 4. Oxytocin+Stress group (treated with
oxytocin and exposed to shock). For practical purposes the rats were split into 3
cohorts, testing n=2 rats from each treatment group at a time (2-3 month
timeframe).
General housing
Rats were housed individually to most effectively monitor food consumption
during behavioral tasks. Rats were housed in a polysulfone filter top cage. Cages
contained corn cob bedding, PVC pipe, and water supplied ad libitum. “Harlan 2018”
food was provided ad libitum, except during the weeks of food deprivation
7

(described below). All rats were housed in the same room kept at a temperature of
22 + 1°C, and a humidity of 23-33% with a 12 hour light/dark cycle.
Reward Training
Prior to oxytocin treatment and fear conditioning (foot shock), all rats were
pre-trained to expect and retrieve a food reward (Kellogg’s Froot Loop) in a circular
open field enclosure (3-ft x 3-ft, 1-ft walls) with a reward delivery tube at one end
(Fig. 1). For one week, rats were habituated to the enclosure by allowing them to
roam freely for a minimum of 5-10 minutes a day (Monday-Friday), three Froot
Loops were delivered into the chamber during this time to familiarize them to the
reward delivery procedure and assess their interest in the food reward. For the next
2-3 weeks rats were food restricted, placed in a start box in the open field enclosure
and 3 Froot Loops were delivered independently into the reward-seeking area (Fig.
1). For each reward-seeking trial, the rat was placed in the start box, the Froot Loop
was delivered and the start box door was opened manually by the experimenter.
The time for the rat to retrieve the reward (within a minute of reward delivery) was
monitored and recorded as an assessment of their “reward-seeking” behavior.
Food Deprivation
After the first week of habituation, rats were food restricted on MondayFriday and fed ad libitum on the weekends. Rats were weighed daily while food
restricted and given an amount of food that correlated to their weight change. Rats
who lost 0-5 grams, or gained weight were fed one half of a food pellet, those who
lost 6-10 grams were fed 1 pellet, rats who lost 11-15 grams were fed 1.5 pellets and
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those who lost 15 grams or more were fed 2 pellets. Rats who drop below 80% of
their starting weight during food restriction would have been fed ad libitum, though
there were no instances of this in our study.
Oxytocin Administration
Rats were lightly anesthetized with isoflurane to calm them sufficiently to
allow for intranasal administration. The Oxytocin+Stress and the Oxytocin groups
were treated with intranasal oxytocin at 0.1 µL/kg, 30 minutes prior to fear
conditioning (described below) based on Ayers et al. (2011) procedure. The Control
and Stress groups were administered an equivalent amount of saline. The rats were
then assessed for fear, anxiety and reward-seeking behaviors (described below).
Fear Conditioning
The Stress and Oxytocin+Stress groups were exposed to an electric foot-shock
paradigm (used as a model for a PTSD inducing stressor; Gao et al, 2014). Over a
period of three days, rats in these groups were exposed to foot shock twice daily.
They were placed into the fear-conditioning chamber twice daily and given 20
inescapable foot shocks (8 mA intensity, 3 second duration, 10 second intervals
between shocks; similar to Gao et al., 2014).
Behavioral Assessments
After oxytocin and shock treatments, all rats were reintroduced to the shock
chamber to assess behaviors related to fear (i.e., time motionless and defecation),
run on an elevated O-maze (Fig. 2) to assess behaviors related to increased anxiety
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(i.e., decrease in time spent in the open segments of the maze), and given three
reward delivery trials in the open field enclosure to assess reward-seeking behavior
(i.e., time to retrieve reward).
Rats were placed in the shocking chamber for five minutes, but not shocked,
to observe fear related behaviors. Fear is often expressed and measured by an
increase in freezing time (defined as the absence of all movements except for those
related to respiration; Gao et al. 2014) and by an increase in fecal production (Gao et
al., 2011) when reintroduced into the fear conditioning (shocking) chamber.
Therefore, the rats were put back into the shocking chamber for 5 minutes and were
observed for freezing time and the amount of fecal production.
To assess anxiety, the rats were placed in an elevated O-maze for five
minutes, measuring the amount of time spent in the open segments which is
inversely correlated to anxiety level of the animal as proposed by Shepherd et al.
(1994). The elevated O-maze (Fig. 2) consisted of an annular platform elevated 65
cm above the floor (105 cm in diameter, 10 cm in width), the platform of the
elevated O-maze was divided into 4 segments: 2 opposing open segments with no
walls, and 2 opposing closed segments with walls extending 27 cm above the
platform surface. The O-maze was located in an otherwise empty room and the
researcher stepped out of room and closed the door once rat was placed in the open
segment of the O-maze as to not distract from the rats normal exploratory behavior.
Behavior was recorded on video for later analysis.
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To assess reward-seeking behavior, the rats were then placed in the open
field enclosure (Fig. 1) for 3 consecutive 1-minute trials, based on the reward
training procedure. At the beginning of each trial, the rat was enclosed in a start box.
The start box door was opened and a Froot Loop (food reward) delivered through
the reward delivery tube. The time to retrieve the Froot Loop was measured.
Behavior was recorded on video for later analysis.
All behavioral tests were done twice: week 1 (anxiety tested 1 day after
shock treatment, fear and reward-seeking tested 2 days after shock treatment) and
again in week 2 (anxiety tested 8 days after shock treatment, fear and rewardseeking tested 9 days after shock treatment).
Statistical analysis
To determine significant differences in behavioral (dependent) measures, we
first compared data from all four groups using a one-way ANOVA (VassarStats). If
overall significance (p ≤ 0.05) was found, a subsequent Tukey’s post-hoc analysis
was used to determine significant differences between individual groups. Standard
two-tailed t-tests (VassarStats) were used to analyze changes within groups
between week one and two. We were particularly interested in the differences
between the Stress and Stress+Oxytocin groups to most directly address the
objectives of this study.
The procedures described in this proposal have been reviewed and approved by the
Eastern Washington University Institutional Animal Care and Use Committee (effective
June 7, 2016).
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Results
For behavioral measures assessing fear, we found overall significance in both
measures (freezing and defecation), during both week 1 and week 2 (Fig. 3,
p<0.0001; Fig. 4, p<0.001; Fig. 7, p<0.0005; Fig. 8, p<0.05). Freezing time in seconds
was significantly lower for Control, Oxytocin, and Oxytocin+Stress groups when
compared to the Stress group (Fig. 3, p<0.01) during week 1. In week 2, the
decreased freezing time between the Stress group and the Oxytocin and Control
groups remained significant (Fig 7, p<0.01) but the Oxytocin+Stress group was no
longer significantly lower than the Stress group, or significantly higher than the
Control group (Fig 7). When comparing week 1 to week 2, the freezing times for the
Stress group shows a significant decrease over time (Fig.11, p<0.05) while this
decrease for the Oxytocin+Stress group was not significant across the two weeks (Fig.
11).
Fecal Production (measured in grams of feces) was significantly lower for
Control, Oxytocin, and Oxytocin+Stress groups when compared to the Stress group
(Fig. 4, p<0.05) in week 1 after fear conditioning. By week 2 the Stress group was
still significantly higher than the Oxytocin and Control groups (Fig 8, p<0.01) but the
Oxytocin+Stress group was no longer significantly lower than the Stress group, or
significantly higher than the Control group (Fig 8).
Tests for anxiety and reward seeking behavior failed to produce significant
results in either week 1 or week 2 (overall one-way ANOVA; Fig. 5, p=0.15; Fig. 6,
p=0.47; Fig. 9, p=0.68; Fig. 10, p=0.55).
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Discussion
It is clear that the PTSD paradigm worked to induce fear in the rats based on
the differences between the Control and Stress groups (Fig. 3-4, Fig.7-8). These
results also supported our hypothesis that prophylactic oxytocin treatment would
decrease fear related behaviors after a PTSD-like stressor. While the Oxytocin+Stress
group had increased fear related behaviors compared to the Control group, both the
time spent freezing (Fig. 3) and the amount of fecal production (Fig. 4) were
decreased significantly compared to the Stress group. However, the significant
difference in fear related behaviors between the Stress and Oxytocin+Stress groups
does not continue in the second week post stressor (Fig. 7-8). This lack of
significance could be due to the attenuation of fear responses over time in the Stress
group which decreased from week one to week two, as opposed to diminished
efficacy of the prophylactic treatment in the Oxytocin+Stress group, which also
decreased in fear related measures but were not significant (Fig. 11).
As there was no significance in anxiety related behaviors between the Control
and the Stress groups (Fig. 5 and Fig. 9), it appears our paradigm did not work for
testing or invoking these symptoms. It is unclear why the elevated O-maze did not
produce results as it has shown to be reliable in other similar tests of the PTSD-like
model (Gao et al., 2014; Renicker et al., 2015). Gao et al. (2014) who developed the
PTSD-like model in rats used an elevated plus-maze to test anxiety so their results
cannot be compared directly to our O-maze results, although a similar effect would
be expected. One possible explanation is the temporal sequence of testing, Gao et al.
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(2014) performed the elevated plus-maze test after re-exposure to the fear
conditioning chamber while our elevated O-maze tests were done the day before reexposure. Renicker et al. (2015) also tested the elevated O-maze after re-exposure
to the fear conditioning chamber, although there was a gap of time (5 days) between
the tests. Previous research has suggested that a reminder of the stress experience
can influence memory and behavior (Zoladz et al., 2010; Burke et al., 2013). As such,
it is possible that the re-exposure to the fear-conditioning chamber enhanced the
anxiety response seen in the previous studies of Gao et al. (2014) and Renicker et al.
(2015).
There was also a lack of significance in reward-seeking behaviors between
the Control and the Stress groups (Fig. 6 and Fig. 10). Since reward-seeking
behaviors have not been analyzed in the rodent model of PTSD, it is possible that
these behaviors are not affected in rodents as is found in human cases of PTSD.
Alternatively, since the reward-seeking paradigm used in this study was developed
in our lab as a cost effective substitute to the classical operant box, it is possible that
these reward-seeking behaviors are impacted in the rat model of PTSD but our
dependent measures did not expose these effects. If this experiment were to be
repeated, it might benefit from the use of operant boxes as has been used in
previous studies to assess reward-seeking behaviors (Dingess et al., 2017;
Piantadosi et al., 2017).
An important aspect to consider is the timing of “prophylaxis”. While our
study defined prophylaxis as treatment prior to the traumatic stressor, other studies
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define preventative treatment as interventions performed soon after the traumatic
event before symptoms of PTSD manifest, also called “early intervention” (Vaiva et
al., 2003; Baker et al., 2009; Daskalakis et al., 2013; Rothbaum et al., 2014; Frijling et
al., 2014; Renicker et al., 2015). Early intervention or prophylactic treatments could
also be affecting different mechanisms than traditional treatments, such as memory
consolidation (Morena et al., 2017). Future studies should evaluate the pros and
cons of each method. Treatment after the traumatic event would be most practical
as the vast majority of traumatic events cannot be predicted; however, if treatment
before a traumatic stressor offers significant protection it could be beneficial in
settings such as combat warfare, law enforcement operations, and surgical settings.
Whether oxytocin treatment is delivered soon after the traumatic event
(Frijling et al., 2014; Renicker et al., 2015; van Zuiden et al., 2017) or before, as was
done in this study, research suggests that intranasal oxytocin administration
provides neuroprotection and attenuates fear related behaviors in humans (Frijling
et al., 2014; van Zuiden et al., 2017) and rodents (Renicker et al., 2015). The direct
effects of oxytocin on brain regions that contain oxytocin receptors and process
emotion (e.g., amygdala) are likely implicated in the behavioral changes we
observed in the measures of fear. Furthermore, PTSD has been shown to alter
endocrine output related to the HPA axis (reviewed in Daskalakis et al., 2013).
Intranasal oxytocin administration is likely impacting the HPA axis but how
oxytocin alters the HPA axis is poorly understood (reviewed in Stockhorst and
Antov, 2016).
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Certain factors should be considered when designing future studies. Genetics
and epigenetics both play a role in the likelihood of developing PTSD (Yehuda &
Bierer 2009; Gerritsen et al., 2017) as well as the potential for treatment success
(Yehuda et al., 2013). Additionally, sex differences are found to be very pronounced
in the instances of PTSD (2:1 female to male ratio) (Kilpatrick et al., 2013) and
oxytocin efficacy (Sack et al., 2017; Smith & Wang 2013). As our study population
consisted of only male rats we were not be able to address these differences. Many
factors influence the probability of developing PTSD. In humans, while
approximately 80% of the population is exposed to traumatic stressors, only a small
percentage (~11%) of them go on to develop the disorder (Kilpatrick et al., 2013).
Therefore, a relatively small study such as ours may not see a large enough sample
of affected individuals to gain an accurate representation of the effects.
The results of this study suggest that further testing is warranted to ascertain
whether or not prophylactic oxytocin treatment is an effective and practical
prevention method for PTSD. Our fear results corroborate the findings of van Zuiden
et al. (2017) Friljing et al. (2014) and Renicker et al. (2015); however, the impact of
prophylactic oxytocin treatment on anxiety and reward seeking need further
investigation.
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Figure 1. Schematic diagram of open field enclosure and reward delivery area.
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Figure 2. Rat in the enclosed area of the elevated zero maze.
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Figure 3. Time spent motionless (freezing) during 5 minute re-exposure to the foot
shock chamber following oxytocin pretreatment (n=6, per group) week one post
stress. Overall significant difference by ANOVA p<0.0001
* significantly different than Oxytocin+Stress p<0.05;
+ significantly different than Control and Oxytocin p<0.05
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Figure 4. Fecal production during 5 minute re-exposure to the foot shock chamber
following oxytocin pretreatment (n=6, per group) week one post stress. Overall
significance by ANOVA p<0.001;
* significantly different than Oxytocin+Stress p<0.05;
+ significantly different than Control and Oxytocin p<0.05
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Figure 5. Time spent in the open arm during 5-minute exposure to the elevated
zero maze following oxytocin pretreatment (n=6, per group) week one post stress.
There was no significant difference between the groups p=0.15
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Figure 6. Average time across 3 trials to retrieve food reward (Froot Loop) in open
field enclosure following oxytocin pretreatment (n=6, per group) week one post
stress. There was no significant difference between groups p=0.47
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Figure 7. Time spent motionless (freezing) during 5-minute re-exposure to the foot
shock chamber following oxytocin pretreatment (n=6, per group), week two post
stress. Overall significance from ANOVA p<0.0005
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Figure 8. Fecal production during 5-minute re-exposure to the foot shock chamber
following oxytocin pretreatment (n=6, per group), week two post stress. Overall,
p=0.016;
+ significantly different than Control and Oxytocin p<0.05
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Figure 9. Time spent in the open arm during 5 minute exposure to the elevated zero
maze following oxytocin pretreatment (n=6, per group) two weeks post stress.
There was no overall significance between groups p=0.68.
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Figure 10. Time to retrieve food reward (Froot Loop) in open field enclosure
following oxytocin posttreatment pretreatment (n=6, per group) two weeks post
stress. p=0.55

Freezing Time (s)

250
200

*

150
Week1
Week 2

100
50
0
Stress

Oxytocin+Stress

Figure 11. Comparison of freezing times between week 1 and week 2 in Stress and
Oxytocin+Stress groups.
* p<0.05 two-tailed t-test
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